Franklin Resources’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.71M | Buy |
2,667,412
+85
| +0% | +$309 | ﹤0.01% | 1142 |
|
|
2025
Q1 | $5.12M | Buy |
2,667,327
+2,500,143
| +1,495% | +$4.8M | ﹤0.01% | 1334 |
|
|
2024
Q4 | $318K | Hold |
167,184
| – | – | ﹤0.01% | 2474 |
|
|
2024
Q3 | $221K | Buy |
+167,184
| New | +$221K | ﹤0.01% | 2600 |
|
|
2024
Q1 | – | Sell |
-65,083
| Closed | -$80.7K | – | 2851 |
|
|
2023
Q4 | $80.7K | Hold |
65,083
| – | – | ﹤0.01% | 2485 |
|
|
2023
Q3 | $74.2K | Sell |
65,083
-17,390
| -21% | -$19.8K | ﹤0.01% | 2482 |
|
|
2023
Q2 | $75.5K | Hold |
82,473
| – | – | ﹤0.01% | 2561 |
|
|
2023
Q1 | $46.2K | Hold |
82,473
| – | – | ﹤0.01% | 2193 |
|
|
2022
Q4 | $47.6K | Hold |
82,473
| – | – | ﹤0.01% | 2217 |
|
|
2022
Q3 | $26K | Hold |
82,473
| – | – | ﹤0.01% | 2240 |
|
|
2022
Q2 | $29K | Sell |
82,473
-39,922
| -33% | -$14K | ﹤0.01% | 2284 |
|
|
2022
Q1 | $88K | Buy |
122,395
+697
| +0.6% | +$501 | ﹤0.01% | 2314 |
|
|
2021
Q4 | $275K | Sell |
121,698
-302
| -0.2% | -$682 | ﹤0.01% | 2114 |
|
|
2021
Q3 | $351K | Buy |
+122,000
| New | +$351K | ﹤0.01% | 2027 |
|
|
2015
Q1 | – | Sell |
-86,500
| Closed | -$1.01M | – | 1582 |
|
|
2014
Q4 | $1.01M | Sell |
86,500
-335,000
| -79% | -$3.9M | ﹤0.01% | 1386 |
|
|
2014
Q3 | $9.33M | Sell |
421,500
-88,900
| -17% | -$1.97M | ﹤0.01% | 1049 |
|
|
2014
Q2 | $14.2M | Buy |
+510,400
| New | +$14.2M | 0.01% | 966 |
|